MET and hepatocellular carcinoma: Gene expression analysis of HCC specimens from The Cancer Genome Atlas-Liver Hepatocellular Carcinoma (TCGA) database suggests that samples with TP53 mutations are more likely to show upregulation of the c-MET signature.